neuroClues Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 29

Employees

  • Latest Deal Type
  • Crowdfunding
  • (Announced)

  • Investors
  • 18

neuroClues General Information

Description

Operator of a MedTech company aiming to become the brain's stethoscope while revolutionizing the early diagnosis of neurological disorders such as Parkinson's and Alzheimer's. The company offers AI-driven eye-tracking technology that enables clinicians to detect brain health issues earlier, improving patient outcomes and treatment strategies.

Contact Information

Formerly Known As
P3Lab
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Avenue Jean Monnet 1
  • 1348 Louvain-la-Neuve
  • Belgium
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Corporate Office
  • Avenue Jean Monnet 1
  • 1348 Louvain-la-Neuve
  • Belgium

neuroClues Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

neuroClues Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Equity Crowdfunding 01-Jan-2026 Announced Generating Revenue
6. Later Stage VC 07-Apr-2026 Completed Generating Revenue
5. Early Stage VC (Series A) 16-Apr-2024 Completed Generating Revenue
4. Accelerator/Incubator Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Grant 19-Dec-2022 $2.62M $5.45M Completed Generating Revenue
1. Seed Round 08-Nov-2021 $5.45M $5.45M Completed Generating Revenue
To view neuroClues’s complete valuation and funding history, request access »

neuroClues Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Class B
Class B
To view neuroClues’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

neuroClues Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a MedTech company aiming to become the brain's stethoscope while revolutionizing the early diagnosis of neur
Diagnostic Equipment
Louvain-la-Neuve, Belgium
29 As of 2026

Holliston, MA
 

Trondheim, Norway
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

neuroClues Competitors (5)

One of neuroClues’s 5 competitors is NeuroSync, a Venture Capital-Backed company based in Holliston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NeuroSync Venture Capital-Backed Holliston, MA
BulbiTech Venture Capital-Backed Trondheim, Norway
NeuraLight Venture Capital-Backed Tel Aviv, Israel
RightEye Venture Capital-Backed Bethesda, MD
Suricog Venture Capital-Backed Paris, France
You’re viewing 5 of 5 competitors. Get the full list »

neuroClues Patents

neuroClues Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4402648-A1 Method for detecting a movement of a body Active 24-Oct-2022
EP-4402648-B1 Method for detecting a movement of a body Active 24-Oct-2022
EP-4402648-C0 Method for detecting a movement of a body Active 24-Oct-2022
US-20260165579-A1 Method for detecting a movement of a body Pending 24-Oct-2022
WO-2024088981-A1 Method for detecting a movement of a body Inactive 24-Oct-2022 G06V40/18
To view neuroClues’s complete patent history, request access »

neuroClues Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

neuroClues Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Teampact Ventures Venture Capital Minority
Wallonie Entreprendre Growth/Expansion Minority
LeanSquare Venture Capital Minority
White Fund PE/Buyout Minority
W.IN.G Venture Capital Minority
You’re viewing 5 of 18 investors. Get the full list »

neuroClues FAQs

  • When was neuroClues founded?

    neuroClues was founded in 2020.

  • Where is neuroClues headquartered?

    neuroClues is headquartered in Louvain-la-Neuve, Belgium.

  • What is the size of neuroClues?

    neuroClues has 29 total employees.

  • What industry is neuroClues in?

    neuroClues’s primary industry is Diagnostic Equipment.

  • Is neuroClues a private or public company?

    neuroClues is a Private company.

  • What is neuroClues’s current revenue?

    The current revenue for neuroClues is .

  • How much funding has neuroClues raised over time?

    neuroClues has raised $22.4M.

  • Who are neuroClues’s investors?

    Teampact Ventures, Wallonie Entreprendre, LeanSquare, White Fund, and W.IN.G are 5 of 18 investors who have invested in neuroClues.

  • Who are neuroClues’s competitors?

    NeuroSync, BulbiTech, NeuraLight, RightEye, and Suricog are competitors of neuroClues.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process